BusinessCircleBusinessCircle
  • Home
  • SMEs
  • Startups
  • Markets
  • Finances
  • HR
  • Marketing & Sales
  • Technology
Facebook Twitter Instagram
Thursday, June 5
  • About us
  • Advertise with us
  • Submit Articles
  • Privacy Policy
  • Contact us
BusinessCircleBusinessCircle
  • Home
  • SMEs
  • Startups
  • Markets
  • Finances
  • HR
  • Marketing & Sales
  • Technology
Subscribe
BusinessCircleBusinessCircle
Finances

Nice CEO: Our cash gives us a competitive advantage

Hezi SternlichtBy Hezi SternlichtAugust 19, 2022No Comments3 Mins Read

[ad_1]

The falls on world inventory markets earlier this yr led to a sobering up on the a part of buyers concerning the values of many know-how firms. The Nasdaq was down over 30% in June, however since then the pattern has modified, and it’s now simply 17% beneath the place it was at the start of the yr.

For all of the turbulence, the enterprise of Good Methods (Nasdaq: NICE; TASE: NICE), headed for the previous eight years by Barak Eilam, has been steady. Good Methods is a veteran Israeli know-how firm that develops techniques for prevention of monetary fraud and for buyer relations administration.

Nonetheless, even Good Methods has been affected by the unfavorable sentiment in the direction of the know-how sector. For the reason that starting of this yr, its share value has fallen 21%, and it has misplaced its standing as probably the most helpful firm on the Tel Aviv Inventory Alternate. Its market cap is NIS 49 billion, NIS 7 billion lower than that of Financial institution Leumi.

Good Methods’ second quarter outcomes present the corporate because the accountable grownup of the native know-how sector. Quarterly income grew 16% to $531 million and internet revenue on a GAAP foundation shot up 45% to $65.6 million.

For the primary half yr, income was $1.06 billion, and internet revenue rose 27% to $123 million. The corporate raised its steering for 2022, and it now sees income totaling $2.17-2.19 billion for the yr. Earlier steering was $2.16-2.18 billion. Non-GAAP totally diluted earnings per share at the moment are anticipated to be in a variety of $7.33 to $7.53, which compares with a earlier steering vary of $7.25 to $7.45.

Regardless of the outcomes and the raised steering, Good Methods’ share value fell by 4.14% in Tel Aviv in the present day, and it’s at the moment down 3.19% in New York.

Summing up the quarter, Eilam says, “What characterizes Good is that whether or not the markets are up or down, we’re steady. Our options are mission essential for our prospects, so they need us in any state of affairs.”

How has Good Methods been affected by the turbulence available on the market?

“We’ve got suffered much less from the declines which have taken place this yr, and it’s not solely the buyers who’ve benefitted; the staff have too. Whereas goals have been shattered in lots of different know-how firms, Good’s workers, yearly in recent times, have redeemed shares to the tune of about $200 million. This isn’t digital paper however actual money that goes to their financial institution accounts. This yr too, I estimate that the staff will understand shares amounting to some $200 million.”

What are your conclusions from the top of the free cash period in know-how?

“The present state of affairs will train the know-how world that whereas progress is necessary, firms additionally must generate earnings. I believe that, trying forward ten years, the current state of affairs will assist the business.”

Eilam says that Good Methods might exploit the sharp falls in lots of know-how shares. “One in every of our benefits is that we have now $1.5 billion money. In our ecosystem, most of our opponents have excessive debt and little money. This creates a aggressive benefit for us.”

Printed by Globes, Israel enterprise information – en.globes.co.il – on August 18, 2022.

© Copyright of Globes Writer Itonut (1983) Ltd., 2022.


[ad_2]

Source link

Advantage cash CEO Competitive Nice
Hezi Sternlicht

Related Posts

US manufacturing output increases in March; February data revised higher

April 16, 2024

AbbVie to spend $1.9B for long acting injectables (NYSE:ABBV)

April 16, 2024

‘Febrile’ excitement helping early stage AI keep pace with the U.S.

April 16, 2024

Johnson & Johnson (JNJ) earnings Q1 2024

April 16, 2024
Add A Comment

Leave A Reply Cancel Reply

Recent Posts
  • 1win — регистрация в букмекерской конторе 1вин.3658
  • Pin Up Casino Azərbaycan.674
  • Pokerdom – онлайн казино и покер рум.4723
  • 1win — регистрация в букмекерской конторе 1вин.1708
  • Glory Casino Bangladesh.934
© 2025 BusinessCircle.co
  • Home
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Type above and press Enter to search. Press Esc to cancel.